Skip to content

Esketamine for postoperative sleep disturbance: clinical evidence, mechanisms, and future directions.

Qijing Liu, Ying Liu, Qian Fu, Boxiong Gao, Yatao Liu

Frontiers in psychiatry January 1, 2025 DOI: 10.3389/fpsyt.2025.1612230 via PubMed

Summary

AI-generated from the abstract

Postoperative sleep disturbance (PSD) is a common complication after surgery, caused by personal, intraoperative, postoperative, and environmental factors, and it impairs recovery and long-term prognosis. Esketamine, a non-competitive NMDA receptor antagonist and the dextrorotatory isomer of ketamine, has stronger receptor affinity, more significant analgesic effects, and better safety than ketamine. Beyond its sedative, analgesic, and antidepressant properties, emerging evidence suggests esketamine may improve PSD through various mechanisms, though existing research results remain controversial. This article reviews the latest research progress on esketamine for improving PSD, discussing its clinical efficacy and potential mechanisms to guide perioperative anesthesia management and postoperative rehabilitation.

Study at a glance

Characteristics Review Peer reviewed
Topics Esketamine Ketamine
Keywords Nmda receptor antagonist Postoperative sleep disturbance Sleep quality Pharmacology
Citations 2
Key finding Esketamine may improve postoperative sleep disturbance through multiple mechanisms, but existing research results are controversial.

Abstract

Postoperative sleep disturbance (PSD) is a common complication following surgery. Numerous factors can contribute to PSD, including personal factors, intraoperative factors, postoperative complications and environmental factors. PSD can lead to a range of adverse outcomes, severely impairing patients' postoperative recovery and long-term prognosis. Esketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist and the dextrorotatory isomer of ketamine, which has stronger receptor affinity, more significant analgesic effects and better safety than ketamine. In recent years, in addition to the proven sedative, analgesic and antidepressant properties, emerging evidence highlights that esketamine may improve PSD through a variety of mechanisms, but the existing research results are still controversial. This article reviews the latest research progress of esketamine in improving PSD, and discusses its clinical efficacy and potential mechanism of action, in order to provide theoretical basis and practical guidance for optimizing perioperative anesthesia management and promoting postoperative rehabilitation of patients.

Explore topics

Comments

No comments yet.

Log in to comment